Twenty-Four-Hour Ambulatory Blood Pressure Monitoring.

ambulatory blood pressure monitoring blood pressure measurement blood pressure monitor hypertension masked hypertension nocturnal dipping white coat hypertension

Journal

Journal of primary care & community health
ISSN: 2150-1327
Titre abrégé: J Prim Care Community Health
Pays: United States
ID NLM: 101518419

Informations de publication

Date de publication:
Historique:
entrez: 11 7 2020
pubmed: 11 7 2020
medline: 25 6 2021
Statut: ppublish

Résumé

The diagnosis, management, and estimated mortality risk in patients with hypertension have been historically based on clinic or office blood pressure readings. Current evidence indicates that 24-hour ambulatory blood pressure monitoring should be an integral part of hypertension care. The 24-hour ambulatory monitors currently available on the market are small devices connected to the arm cuff with tubing that measure blood pressure every 15 to 30 minutes. After 24 hours, the patient returns, and the data are downloaded, including any information requested by the physician in a diary. The most useful information includes the 24-hour average blood pressure, the average daytime blood pressure, the average nighttime blood pressure, and the calculated percentage drop in blood pressure at night. The most widely used criteria for 24-hour measurements are from the American Heart Association 2017 guidelines and the European Society of Hypertension 2018 guidelines. Two important scenarios described in this document are white coat hypertension, in which patients have normal blood pressures at home but high blood pressures during office visits, and masked hypertension, in which patients are normotensive in the clinic but have high blood pressures outside of the office. The Centers for Medicare and Medicaid Services has made changes in its policy to allow reimbursement for a broader use of 24-hour ambulatory blood pressure monitoring within some specific guidelines. Primary care physicians should make more use of ambulatory blood pressure monitoring, especially in patients with difficult to manage hypertension.

Identifiants

pubmed: 32646277
doi: 10.1177/2150132720940519
pmc: PMC7356999
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2150132720940519

Références

N Engl J Med. 2006 Jul 27;355(4):385-92
pubmed: 16870917
J Hypertens. 2008 Jul;26(7):1290-9
pubmed: 18550999
Blood Press Monit. 2019 Jun;24(3):151-154
pubmed: 30807305
JAMA. 1997 Oct 1;278(13):1065-72
pubmed: 9315764
Hypertension. 2007 Dec;50(6):1019-25
pubmed: 17938383
JAMA. 2002 Feb 27;287(8):1003-10
pubmed: 11866648
J Community Health. 1992 Aug;17(4):247-57
pubmed: 1527245
Ann Intern Med. 2015 Nov 17;163(10):778-86
pubmed: 26458123
J Hypertens. 2013 Jul;31(7):1281-357
pubmed: 23817082
Hypertension. 2019 Sep;74(3):652-659
pubmed: 31327263
J Hypertens. 1994 May;12(5):609-15
pubmed: 7930562
Curr Opin Nephrol Hypertens. 2010 Jan;19(1):51-8
pubmed: 19864947
J Clin Hypertens (Greenwich). 2018 Jul;20(7):1096-1099
pubmed: 30003697
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Blood Press Monit. 2010 Feb;15(1):59-62
pubmed: 20075717
Blood Press Monit. 2015 Oct;20(5):291-4
pubmed: 25932885
Br J Gen Pract. 2020 Jan 30;70(691):90-91
pubmed: 32001477
Proc R Soc Med. 1977 Nov;70(11):793-9
pubmed: 341169
Blood Press Monit. 2010 Aug;15(4):225-8
pubmed: 20216407
JAMA. 1999 Aug 11;282(6):539-46
pubmed: 10450715
Clin Chim Acta. 2017 Feb;465:131-143
pubmed: 28007614
Ann Intern Med. 2015 Feb 3;162(3):192-204
pubmed: 25531400
Nat Rev Neurosci. 2003 Aug;4(8):649-61
pubmed: 12894240
Vasc Health Risk Manag. 2014 May 13;10:303-9
pubmed: 24868162
J Clin Hypertens (Greenwich). 2014 Sep;16(9):624
pubmed: 25087601
J Hum Hypertens. 2017 Feb;31(2):89-92
pubmed: 27411300
N Engl J Med. 2006 Jun 1;354(22):2368-74
pubmed: 16738273
Blood Press Monit. 2007 Oct;12(5):329-33
pubmed: 17890972
Blood Press Monit. 2010 Oct;15(5):275-7
pubmed: 20559140
Blood Press Monit. 2019 Feb;24(1):38-41
pubmed: 30507622
Am J Hypertens. 2011 Jan;24(1):52-8
pubmed: 20847724
Annu Rev Public Health. 2015 Mar 18;36:109-30
pubmed: 25594330
Hypertension. 2005 Jul;46(1):156-61
pubmed: 15939805
Hypertens Res. 2016 Jun;39(6):383-90
pubmed: 26888119
J Hypertens. 2004 Mar;22(3):435-45
pubmed: 15076144
J Am Soc Hypertens. 2014 Dec;8(12):891-7
pubmed: 25492832
Clin Cardiol. 1992 Oct;15(5 Suppl 2):II3-5
pubmed: 1486728
Int J Cardiol. 2017 Mar 1;230:33-39
pubmed: 28034462
J Hypertens. 2010 Oct;28(10):2036-45
pubmed: 20520575
Eur J Pediatr. 2017 May;176(5):573-580
pubmed: 28236027
Hypertension. 2005 Feb;45(2):203-8
pubmed: 15596572
Kardiol Pol. 2019;77(2):71-159
pubmed: 30816983
JAMA. 2004 Feb 25;291(8):955-64
pubmed: 14982911
J Hypertens. 2001 Jun;19(6):995-9
pubmed: 11403368
J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26
pubmed: 24341872

Auteurs

Camilo Pena-Hernandez (C)

Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Kenneth Nugent (K)

Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Meryem Tuncel (M)

Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH